Optimum Imaging Technologies v. Samsung: Camera Patent Dispute Settled

Case Overview

A nearly 20-month patent battle between a Texas-based imaging technology licensor and one of the world’s most dominant consumer electronics manufacturers concluded quietly in May 2025 — not with a jury verdict, but with a negotiated dismissal. In Optimum Imaging Technologies, LLC v. Samsung Electronics Co., Ltd. et al. (Case No. 4:23-cv-00927), the Eastern District of Texas closed the matter on May 27, 2025, when both parties announced a private resolution and requested dismissal with prejudice of the plaintiff’s claims.

The case centered on three U.S. patents covering digital camera imaging technology and named over two dozen Samsung Galaxy and Galaxy Z series smartphones as accused products. For patent attorneys tracking non-practicing entity (NPE) litigation patterns, IP professionals monitoring smartphone imaging IP disputes, and R&D teams managing freedom-to-operate risk across mobile device portfolios, this case offers a compelling lens into how high-stakes imaging patent assertions against large-scale consumer electronics manufacturers typically resolve in today’s litigation environment.

The Parties

The Patents at Issue

Three issued U.S. patents formed the basis of the infringement action:

• • U.S. Patent No. 7,612,805 — directed to digital camera imaging systems and processing methodologies
• • U.S. Patent No. 8,451,339 — covering imaging capture and signal processing techniques
• • U.S. Patent No. 10,877,266 — a more recent patent addressing camera lens and optical imaging system configurations

These patents collectively span imaging capture, optical processing, and camera system architecture — core technology areas embedded in modern smartphone camera modules.

The Accused Products

Optimum Imaging accused a broad portfolio of Samsung devices, including the Galaxy S10, S20, S21, S22, and S23 series (including Ultra, FE, and Plus variants), the Galaxy Z Flip 3, 4, and 5, and the Galaxy Z Fold 2, 3, 4, and 5 — as well as Samsung’s proprietary ISOCELL image sensors. The breadth of accused products signals a wide-net assertion strategy targeting Samsung’s most commercially significant product lines across multiple product generations.

Legal Representation

Plaintiff’s counsel included Carter Arnet PLLC, Cherian LLP, Sanders, Motley, Young & Gallardo PLLC, and Siebman Law (Sherman), with attorneys Roger D. Sanders, Korula T. Cherian, Scott Wayne Breedlove, and Thomas M. Dunham among the team.

Samsung’s defense was led by Greenberg Traurig LLP (across multiple offices), Gillam & Smith LLP, and Husch Blackwell LLP — a formidable multi-firm coalition led by attorneys including Richard A. Edlin, Andrew R. Sommer, and Melissa Richards Smith.

Litigation Timeline & Procedural History

Filed on October 18, 2023, in the Eastern District of Texas, the case was assigned to Chief Judge Amos L. Mazzant — a jurist well known in patent litigation circles for managing complex IP dockets and applying rigorous claim construction standards. The Eastern District of Texas remains one of the most active patent litigation venues in the United States, particularly favored by patent assertion entities for its historically patent-friendly reputation and streamlined local patent rules.

The case ran for 587 days before closing on May 27, 2025 — a duration consistent with cases that proceed through early claim construction phases and discovery before reaching resolution. While no trial date appears to have been reached, the 19-month lifecycle suggests the parties navigated substantial pretrial activity, likely including Markman proceedings, invalidity contentions, and infringement contentions, before determining that private settlement served both parties’ interests more efficiently than continued litigation.

The Verdict & Legal Analysis

Outcome

On May 27, 2025, the court entered an order of dismissal reflecting a negotiated resolution between Optimum Imaging Technologies and Samsung. The dismissal structure is legally significant:

• Plaintiff’s claims dismissed with prejudice — Optimum Imaging cannot re-file the same infringement claims against Samsung for the same accused products and patents in any future action.
• Defendants’ counterclaims and defenses dismissed without prejudice — Samsung’s invalidity counterclaims and related defenses remain legally viable and were not adjudicated on the merits.
• Each party bears its own attorneys’ fees, costs, and expenses — a standard mutual fee-bearing provision consistent with confidential settlement resolutions.

No damages amount was publicly disclosed, which is consistent with confidential licensing or settlement agreements in NPE litigation.

Verdict Cause Analysis

The case was categorized as a straightforward infringement action. No public record of a Markman ruling, summary judgment disposition, or PTAB inter partes review (IPR) outcome is reflected in the available case data, though Samsung’s retention of a large multi-firm defense team suggests that invalidity and non-infringement defenses were actively developed.

The dismissal without prejudice of Samsung’s counterclaims is particularly notable. It suggests Samsung did not extract a formal adjudication of invalidity — a common defensive goal in NPE cases — meaning the three asserted patents survive this litigation legally intact from Samsung’s challenge, at least in the public record.

Legal Significance

The outcome reflects a recurring dynamic in Eastern District of Texas NPE litigation: a well-resourced defendant deploying substantial legal firepower to create settlement pressure, while the plaintiff faces the litigation cost and evidentiary burden of proving infringement across multiple patent families and dozens of accused products. The confidential resolution prevents this case from generating binding claim construction precedent, but the patents’ continued validity and the breadth of accused products may inform future assertion strategies.